UTAH MEDICAL PRODUCTS INC

UTMD stands for Utah Medical Products, Inc., a healthcare company that develops, manufactures, and markets specialized medical devices. Its product lines include devices used in obstetrics, gynecology, neonatal care, and blood pressure monitoring. The company sells primarily to hospitals and clinics, with a significant portion of revenue generated outside the United States.

Recent performance for UTMD can be found in the price chart and performance data on this page. Short-term moves often reflect quarterly results, healthcare sector trends, and broader market conditions. For the latest price change, percentage move, and updated performance figures, refer to the live data displayed on this UTMD stock page.

UTMD's valuation can be assessed using metrics such as the price-to-earnings ratio, price-to-sales, and enterprise value multiples. Comparing these figures with medical device peers and UTMD's own historical averages provides context. Because valuation depends on current price and earnings, use the latest metrics shown on this page rather than fixed numbers.

UTMD may be available for trading in pre-market and after-hours sessions, though liquidity is typically lower than during regular U.S. market hours. Extended-hours trading depends on your brokerage's platform and the availability of counterparties. Investors should be aware that prices can be more volatile and spreads wider when the main market is closed.

Utah Medical Products has a history of paying regular cash dividends, though the amount and frequency can change over time. For the current dividend per share, yield, and payment schedule, consult the dividend information displayed on this UTMD page. Dividend policy is determined by the board and may be affected by earnings and cash flow.

Key metrics for UTMD include revenue growth, gross and operating margins, net income, earnings per share, and return on equity. Cash flow from operations and the balance sheet's cash position also matter. These figures help assess profitability, efficiency, and financial health, and should be reviewed alongside the latest quarterly and annual reports.